Back to Blackstone Inc. Blackstone Inc.

EFTREFTR
Showing 2 of 14 quarters

Position history for Blackstone Inc.Blackstone Inc.'s holdings in EFFECTOR THERAPEUTICS INC

No. Blackstone exited its EFTR (Effector Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 52,343 shares worth $2,041. Blackstone first reported EFTR in Q3 2021 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2,041

Total Shares Change

-52,343

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.04
0
2024-Q3
Unchanged
52,343
0.0%
$2,0410.0%$0.04
0

Other major holders of EFTR: Carlyle Group Inc., NORGES BANK

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used